Taglutimide
| Code | Size | Price |
|---|
| TAR-T34771-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Taglutimide is a sedative-hypnotic derivative of glutarimide.
CAS:
14166-26-8
Formula:
C14H16N2O4
Molecular Weight:
276.29
Purity:
0.98
SMILES:
URPJPYAYMWPUPR-UHFFFAOYSA-N
References
Sch?tzenberger WG, Kolassa N, Wiener H, Kraupp O, Tuisl E. Pharmacological properties of taglutimide, a new sedative-hypnotic drug. Arzneimittelforschung. 1979;29(8):1146-50. PubMed PMID: 583013.
Hofeneder M, Krebs G, Sutter B, Koch HP. [Acute toxicity in the "yeast test" of thalidomide, taglutimide and supidimide]. Pharmazie. 1993 Feb;48(2):147-8. German. PubMed PMID: 8475162.
Wiener H, Krivanek P, Tuisl E, Kolassa N. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. Eur J Drug Metab Pharmacokinet. 1980;5(2):93-7. PubMed PMID: 6156838.
Fiebrich F, Pischek G, Koch H. Pharmacokinetics and metabolism of taglutimide (K-2004) in the rat. Arzneimittelforschung. 1979;29(7):1036-41. PubMed PMID: 582995.